A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 1,266 shares of NVS stock, worth $132,018. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,266
Previous 936 35.26%
Holding current value
$132,018
Previous $99.6 Million 46.13%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$106.13 - $120.89 $35,022 - $39,893
330 Added 35.26%
1,266 $146 Million
Q1 2024

May 10, 2024

BUY
$95.27 - $108.47 $89,172 - $101,527
936 New
936 $94 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Foster Dykema Cabot & Partners, LLC Portfolio

Follow Foster Dykema Cabot & Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Dykema Cabot & Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foster Dykema Cabot & Partners, LLC with notifications on news.